Info Request | Media centre | Newsletter | Site Map | in French | Search the site:

GMAP Financing

Some 3.3 billion people are at risk of malaria around the world. In 2012, there were about 207 million malaria cases and 627 000 malaria deaths, mostly among African children. Scaling up prevention and treatment interventions in endemic countries is crucial to progress toward the Roll Back Malaria objectives of reducing global malaria cases by 75% (from 2000 levels) and reaching near-zero malaria-related deaths by end 2015.

The investment in malaria control is an investment in development, because malaria is inextricably linked with poverty. The highest malaria mortality rates are being seen in countries that have the highest rates of extreme poverty (proportion of population living on less than US$ 1.25 per day).

Financing for malaria has increased dramatically in the past decade. However, in the context of the current financial and economic vulnerability of traditional donors, recent funding trends show a growing challenge. Increased resources as well as better value for money in the form of technological innovation, better integrated services, cost efficiencies and new partnerships are urgently needed to address the outstanding financing gaps in countries and maintain the gains made over the past decade.

To respond to this challenge, the RBM Board issued in 2011 and updated in 2012 a resource mobilization strategy to fill the GMAP funding gap for the years 2012-2015.